# Pathways of Eicosanoid Metabolism

> **NCT04464070** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Vanderbilt University** · enrollment: 10 (estimated)

## Conditions studied

- Metabolism of Prostaglandin D2

## Interventions

- **DIETARY_SUPPLEMENT:** niacin
- **DRUG:** aspirin
- **OTHER:** PGD2

## Key facts

- **NCT ID:** NCT04464070
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-08-15
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464070, "Pathways of Eicosanoid Metabolism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04464070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*